Intermediate for Apixaban. Apixaban (trade name: Eliquis) is a direct factor Xa inhibitor for the treatment of venous thromboembolic events. Apixaban has been approved by the U.S Food and Drug Administration on March 18, 2014.
Product Name: 5,6-Dihydro-3-(4-morpholinyl)-1-(4-nitrophenyl)-2(1H)-pyridinone
CAS Number: 503615-03-0
Molecular Weight:  303.317
Molecular Formula:  C15H17N3O4
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.